The Nasdaq Composite faces its worst day in a month due to tech stock declines. Investors should reassess portfolios, exploring opportunities in health care and basic materials.
A rally in drug stocks has driven the Dow and S&P 500 to record highs, showcasing resilience in healthcare despite economic challenges like a government shutdown.
Explore how stock investors can benefit from the booming corporate bond market. Discover top companies like Merck, J&J, and Microsoft leveraging bonds for growth and stability.
The S&P 500 has turned positive for 2025, signaling a market recovery. Discover key stocks like Apple, Berkshire, and Merck poised for growth amid renewed investor confidence.
Consumer sentiment hits a low of 50.8 amid inflation fears. Explore implications for investors and key stocks like Walmart, UnitedHealth, and Coinbase in this analysis.
Explore Merck's 2024 financial performance with $64.168B revenue and $17.117B net income. A compelling buy for investors seeking growth in the pharmaceutical sector.